0001209191-21-046802.txt : 20210715
0001209191-21-046802.hdr.sgml : 20210715
20210715173347
ACCESSION NUMBER: 0001209191-21-046802
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210714
FILED AS OF DATE: 20210715
DATE AS OF CHANGE: 20210715
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Wendy S.
CENTRAL INDEX KEY: 0001652822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40315
FILM NUMBER: 211093527
MAIL ADDRESS:
STREET 1: 800 E. LEIGH STREET
STREET 2: SUITE 209
CITY: RICHMOND
STATE: VA
ZIP: 21219
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Reneo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001637715
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472309515
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: (858) 283-0280
MAIL ADDRESS:
STREET 1: 12230 EL CAMINO REAL
STREET 2: SUITE 230
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-07-14
0
0001637715
Reneo Pharmaceuticals, Inc.
RPHM
0001652822
Johnson Wendy S.
C/O RENEO PHARMACEUTICALS, INC.
12230 EL CAMINO REAL, SUITE 230
SAN DIEGO
CA
92130
0
1
0
0
Chief Development Officer
Common Stock
2021-07-14
4
S
0
111736
8.50
D
0
D
The Reporting Person previously notified the Issuer of her intention to retire from her position as the Issuer's Chief Development Officer, effective on or before December 31, 2021. Following her announcement, the Reporting Person exercised an option totaling 111,736 shares of Common Stock of the Issuer (the "Shares") on July 8, 2021. The Reporting Person is selling the Shares privately to Abingworth Bioventures 8 LP ("Abingworth"), an existing stockholder of the Issuer. Bali Muralidhar, a Director of the Issuer, is a member of the investment committee of Abingworth.
/s/ Vineet R. Jindal, Attorney-in-Fact
2021-07-14